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Overview
• Antimicrobial use in humans and animals
• Dairy farm antimicrobial usage
• Pathogen based treatment (PBT)
Pop quiz
• What is the percentage of mastitis cultures that 
are culture negative?
• What percentage of mastitis causing organisms 
are treatable or respond to intramammary 
treatment?
• How many dairy producers in the room have a 
MAST No Treat protocol?
The role of antimicrobials in human 
and animal medicine
• Antimicrobials – medicine that inhibits the growth of or destroys 
microorganisms
– Some antimicrobials specifically target bacterial cells
– Human cells have a plasma membrane but lack a peptidoglycan cell wall structure
• Beta-lactams selectively target bacteria with a peptidoglycan layer with no negative impact on 
human cells
• Antimicrobials have and continue to save millions of lives
• Antimicrobials improve human health
• Lifespan
– 1930 – 60 years
– 2016 – 78 years
• Use of antimicrobials in animal medicine
– Lower mortality rate
– Lower morbidity rate
– Lower disease rates – increased risk of another disease when sick
What were the major 
killer of humans in the 
1930? 
What are the major 
killers of humans today?
CDC, NCHS
Main causes of 
death in 1900’s 
was from 
diseases caused 
by bacteria.  
Today bacterial 
deaths are very 
few compared to 
other diseases
So what’s the problem…?
• Concern from public health, food safety, and 
regulatory perspectives about the use of 
antimicrobials in food-producing animals….
• This is not new
– In 1987 three out of five consumers viewed antimicrobial 
use in poultry and livestock as a “serious health hazard”
– Historical data from 1937 to 1991 shows that food safety 
was the number one topic of discussion among 
consumers as it related to food
• Food safety was of greater concern than excess consumption 
of a food product, pesticides residues in food, animal hormones 
and unsafe practices used to treat cattle
• The discussion is not that different today
– Need to educate on prudent use not reduction
Bulk tank milk testing
• Every load of milk is tested for the presence of Beta-
lactam drugs
– > 3.4 million loads tested annually
• 0.011% test positive
Milk residue sampling survey
Target farms Non-target farms
antimicrobial negative 953 959
antimicrobial positive 11 (12) 4
antimicrobial positive 
(%) 1.15% 0.42%
USDA Dairy 2014
• 90% of operations use IMM antimicrobials
– 87% of cows with mastitis treated with IMM
– 21% of cows affected with mastitis during lactation
– 93% of cows are dry treated with an antimicrobial
• Not focusing on use of antimicrobials in non-
lactating animals during this presentation
– But…..
History of antimicrobials in feed
• 1951 FDA approves antimicrobials for use in animal feed based on studies showing it helps chickens, pigs and 
livestock improve weight gain
• 1969 A committee of government experts in the U.K. concludes that the use of antimicrobials in animals has 
contributed to antimicrobial resistance in humans
• 1970 A U.S. task force, including scientists from the FDA and other agencies, recommends some antimicrobials 
used in humans be banned from use in animals
• 1977 The FDA proposes a ban on the use of penicillin and tetracycline in animal feed, unless pharmaceutical 
makers can show the practice is not a danger to humans
• 1980 FDA-commissioned report by the National Academy of Sciences finds little scientific data on antimicrobial 
resistance caused by feeding drugs to animals
• 1997 World Health Organization recommends antimicrobials used in humans should not be used to promote 
growth in animals.
• 1999 The European Union issues a ban on using popular human antimicrobials in animals for growth promotion 
due to risks to humans
• 2003 U.S. Institute of Medicine issues a report on the rise in dangerous bacteria, or superbugs. The group's 
recommendations include banning use of antimicrobials for growth promotion in animals.
• January 2012 The FDA orders limits on cephalosporin antimicrobials given to animals. The drugs are used to treat 
pneumonia and other diseases in humans.
• April 2012 The FDA outlines plans to phase out non-medical uses of more than 200 antimicrobials in animals over 
three years. 
• 2015 FDA implements animal drug regulations regarding veterinary feed directive (VFD) drugs. FDA's current VFD 
regulation established requirements relating to the distribution and use of VFD drugs and animal feeds containing 
such drugs. This amendment is intended to improve the efficiency of FDA's VFD program while protecting human 
and animal health.
• 60% of AMU in dairy is for mastitis or milk quality (MAST and dry cow)… 
• Limited number of approved intramammary antimicrobials
• 5/6
PolyMast™
2/3 of that 60% is for Dry Cow Therapy
Shouldn’t be a complicated 
discussion…
Quartermaster is on market again too
Mastitis
• Define mastitis
– Inflammation of the mammary tissue
• Abnormal milk, swelling, warmth to the touch, sensitive to touch
• Mastitis is indicated by inflammation or abnormal milk, etc. and 
that is why we have milk samples that culture negative
– The organism may have been evacuated from the mammary gland 
by the time we see abnormal milk and collect a milk sample
– Inflammation caused by response of immune system to 
invading organism or localized trauma
• Not infection but inflammation
– Why is the distinction important?
– We cant treat inflammation with antibiotics
Ruegg et al.
CS=1
48%
CS=2
34%
CS=3
18%
Severity Score Distribution 
Clinical Mastitis on 6 NYS dairies 2016
n=716
Vasquez et al.
< 40% of 
mastitis cases 
require 
treatment if we 
use cure rate 
as an outcome
7.5 5.7
5.4 5.2
5.0 4.1
4.0 1.2 Alanis et al. - unpublished
Treatable:
Streps
Non-treatable:
Gram-
Staph aureus
CNS
No growth
Lactococcus?
9 – 38% 
treatable
Monthly mastitis 
incidence risk of 
4.8%
Pathogen Based Treatment 
Decisions for Clinical Mastitis
• How could delaying treatment of mastitis by 24 – 48 
hours be beneficial to milk quality and clinical 
outcome?
– Not all cases should/need to be treated!
– ~85% of cases are mild or moderate
• Delaying treatment ~ 24 hours doesn’t change outcome
• Don’t need systemic treatment
– ~15% of cases should be treated immediately and 
systemically 
Clinical mastitis score
• Clinical severity score of 1, 2 or 3
– 1: abnormal milk
– 2: swelling or inflammation
– 3: systemic or down cow
• What percent of mastitis cases are clinical score 3?
Design Summary
Randomize cows into two groups:
1. Treat all cows with mild/moderate mastitis 
with 5 days of Spectramast (BT)
a. Cull Myco, Staph aureus, Prototheca
1. Treat some cows based on pathogen ID 
(ToDay or NOT) after 24 hours (PB)
a. Treat Streps, CNS Staphs with Today 2x
b. Cull Myco, Staph aureus, Prototheca
c. Not treat others
2. Cows with CS=3 given systemic therapy and 
not included in analysis
Materials and Methods
1. Compare treatment “success”
a. Next test-day LS
b. Next test-day milk production
c. Duration of clinical mastitis signs
d. Risk of being sold/dead at 30 and 60 d after event
e. Time out of tank
2. Determine risk of chronic E. coli in untreated 
cows compared to treated cows
Does waiting >24 hours for pathogen ID and then treating 
only Streps and Staphs with Today 2x v. treating with 
Spectramast 5x change:
• the length of clinical mastitis signs? – NO
– 4.5d in 24 hr (PB) 
– 4.8d in Spectramast (BT) 
• P= 0.12
Does waiting ~24 hours for pathogen ID and then treating 
only Streps and CNS Staphs with Today 2x v. treating with 
Spectramast 5x change:
• LS at next test day – NO
– 4.3 in 24 hour group (PB)
– 4.3 in Spectramast group (BT)
• P= 0.70
Does waiting ~24 hours for pathogen ID and then treating 
only Streps and CNS Staphs with Today 2x v. treating with 
Spectramast 5x change:
• Milk Production at next test day – NO
– 77.8 lbs in 24 hr group (PB)
– 76.3 in Spectramast group (BT)
• P= 0.42
Does waiting >24 hours for pathogen ID and then treating 
only Streps and Staphs with Today 2x v. treating with 
Spectramast 5x change:
• the risk of being sold/dead  - NO
– Survival at 30d
• OR = 1.6 (95% CI:0.7-3.7) for remaining if in PB
• 3.7% PB v. 5.8 BT
• P=0.31
– Survival at 60d
• OR = 1.4 (95% CI:0.7-2.5) for remaining if in PB
• 9.3% PB v. 11.1% BT 
• P=0.53
Descriptive Results
• 725 cases of clinical mastitis
– 16% had CS=3 (n=114)
• 37 cows culled and excluded for Staph 
aureus or Mycoplasma
• 85 others excluded for other diseases, 
protocol errors, etc.
• 246 Pathogen Based / 243 
Blanket Therapy
– PB: 167 = no treatment; 79 ToDay 
2x
– BT: 243 = Spectramast 5x 
Pathogen PB (%) BT (%)
No growth 26 21
NSO 7 7
CNS 2 3
Strep spp. 31 33
Gram 
negative
34 33
Yeast 0.4 2
T. pyogenes 0.4 0.8
Other 0 0.8
PBT Summary
• 3 less days of milk withhold
– No differences in:
• Days to clinical cure
• Post MAST milk yield
• Post MAST LS 
• Risk of cull in 1-2mo following MAST
• Over 65% of mild/moderate mastitis will NOT be treated with 
antimicrobials if this protocol is employed
• Every farm has different mastitis causing organisms
• $25,000 in economic benefit to the farm / 1,000 cows when 
using PBT vs. blanket treatment
– 5% Mastitis incidence rate
– $15/cwt
Economics: Milk $15/cwt
Table By: Michael Capel and Daryl Nydam; adapted by Rick Watters
79.20 52.20 52.20
105.70 68.15 59.45
15.00
63,420 14,311.50 23,185.50
63,420 37,497
25,923
QMPS 24 hr: 6 - 7d/wk service
• Cows gets mastitis
• Milk samples taken
• Events entered into computer
• Courier picks up samples 
• Accessioned at lab
• Pathogen results reported 24 hours after pick-up
• Protocol driven treatment/automated treatment 
assignment in DC305
• On-farm culture also works for Pathogen Based 
Treatment decision making
Data and Sample Flow 
VAS               
iLOOP
DC 305
Cow ID is 
only entered 
once at farm!! File on USB stick
No 
Treat 
OR 24 hrs
Auto assign Tx
Protocol based 
on pathogen
Enter EVT
Electronic 
Accessioning
D
When Cow 
Entered
When Sample at 
Lab
24 Hour Results
Review MAST treatment protocols - DVM
• When was the last time that you reviewed your 
MAST treatment protocols?
• How many farms have a MAST no treat 
protocol?
Clinical Mastitis Cow 
Move to Hospital Pen (Pen ____) 
Take culture of affected quarter for clinical mastitis cow 
Use STRIP command (clinical quarters) 
Treat systemically as needed (Use SYSMAST event and 
protocols)
Wait for culture result before intramammary treatment
If 24 hr culture result 
is __, __, __, __, __  
* If multiple high CMT quarters, 
sample each quarter individually 
and enter as two separate 
culture events.  
Treat with 
__________ in 
affected quarter 
once daily for 
__ days                
(Protocol #___)
If culture result is 
A, M,  H or R
Any other culture 
result
Check meat 
withholding date 
and cull cow??? 
(No Treat MAST 
event, Protocol 
#___)
No 
intramammary 
treatment (No 
Treat MAST 
event, Protocol 
#___) 
Farm:_________
__
Vet: 
____________
Date: 
___________
If 24 hr culture 
result is R
If cow is Lactation 1 
or 2 then Treat with 
Pirsue in affected 
quarter once daily 
for 7 days. (Protocol 
#__)  If Lact 3 or 
greater then No 
Treat MAST event 
(Protocol #__)
MAST Protocols needed (DC 305 
#)
● __________ 1X for __ days 
(#___)
● __________ 1X for __ days 
(#___)
● __________ 1X for __ days 
(#___)
● No treat for __ days (#___)
If 24 hr culture 
result is __
Treat with 
__________ in 
affected quarter 
once daily for 
__ days                
(Protocol #___)
All clinical mastitis quarter samples and high SCC cow quarter 
samples will get be tested for 
_____________________________(__).  All fresh cow composite 
samples will be tested for __________________ (__).
Fresh Cow composite samples are entered into DC 305 using 
CULTURE command
Veterinarian 
Signature:
_________________
__
Date: 
______________
Clinical Mastitis Cow 
Move to Hospital Pen (Pen 11) 
Take culture of affected quarter for clinical mastitis cow 
Use STRIP command (clinical quarters) 
Treat systemically as needed (Use SYSMAST event and protocols)
Wait for culture result before intramammary treatment
If 24 hr culture result 
is C, D, F, G, or S  
* If multiple high CMT quarters, 
sample each quarter individually 
and enter as two separate 
culture events.  
Treat with 
Spectramast in 
affected quarter 
once daily for 3 
days                
(Protocol #14)
If culture result is 
A, M, or H
Any other culture 
result
Check meat 
withholding date 
and cull cow??? 
(No Treat MAST 
event, Protocol 
#7)
No 
intramammary 
treatment (No 
Treat MAST 
event, Protocol 
#7) 
Farm: 
Pathogen 
Based Dairy 
Vet: Dr. T.
Date:
If 24 hr culture 
result is R
If cow is Lactation 1 
or 2 then Treat with 
Pirsue in affected 
quarter once daily 
for 7 days. (Protocol 
#54)  If Lact 3 or 
greater then No 
Treat MAST event 
(Protocol #7)
MAST Protocols needed (DC 
305 #)
● Spectramast 1X for 3 days 
(#14)
● Spectramast 1X for 5 days 
(#22)
● Pirsue 1X for 7 days (#54)
● No treat for 5 days (#7)
If 24 hr culture 
result is U
Treat with 
Spectramast in 
affected quarter 
once daily for 5 
days
(Protocol #22)
All clinical mastitis quarter samples and high SCC cow quarter 
samples will get an individual aerobic and pooled mycoplasma 
culture (V).  All fresh cow composite samples will be pooled for 
mycoplasma (P).
Fresh Cow composite samples are entered into DC 305 using 
CULTURE command
Pathogen based treatment at QMPS
• > 100,000 cows in NY state on PBT
– Where was this number 5 or 10 years ago?
– Where will this number be 5 or 10 years from now?
– Approximately 35% of cows managed with On-farm 
culture
• NY state most likely has the highest adoption rate 
of PBT than any other state given the ability of 
QMPS to promote the program state wide
• NY State Dairy Statistics
– 4,400 farms
– 623,000 cows
Dry cow therapy
• 2014 NAHMS, USDA survey indicated that 93% 
of cows undergo dry treatment
– 9.39 million dairy cows in US – 2017
– 4 tubes/cow
• Blanket treatment of all cows to control contagious mastitis
• What about selective dry cow therapy?
– Does every quarter of every cow need to be treated 
with intramammary antimicrobials at dry off?
Selective dry cow therapy (SDCT)
• Articles in press over past couple of years on 
SDCT
• Since 2012 no preventive antimicrobials 
allowed in Netherlands
– Bulk tank SCC 170,000 country wide
– Reduced antimicrobial usage by 28%
• New Zealand Veterinary Association states 
by 2020 only cows with an existing 
intramammary infection at dry off can be 
treated
• Strep ag and Staph aureus smaller issue 
today
• From 70 – 95% of cows are culture negative 
at dry off
SDCT
• An approach abolishing the dry treatment of all animals is not suggested
– There are animals that will benefit from intramammary antimicrobials and these 
animals should be dry treated
• How do we identify which animals to treat and not treat at dry off?
– Quarter level culture
• Treat quarters that were culture positive
• Reduced antimicrobial usage by 28%
– Patel, Gordon et al 2017
– SCC data
• SCC < 200,000 cells/ml on last three tests no treat
– 53% of cows low risk
» Rajala-Schultz/Ruegg
– Use of on-farm data and test day
• <200,000 cells/ml at last test
• Average of last three test days < 200,000 cells/ml
• ≤ 1 clinical case of mastitis during lactation
• No current symptoms of mastitis
• No mastitis in last 30 days
– 64% of cows low risk
» Vasquez et al. 2018
SDCT
• Slow adoption from NE to SE to NW to MW
– Farms are working closely with veterinarians
– Superior milk quality should be achieved prior to 
taking on SDCT
– Using multiple criteria to determine if cow is eligible 
for no treat may be beneficial
• Error on the side of treating a few more versus not treating 
cows that should be treated
Potential antimicrobial reduction
• 30 – 65% no treat with PBT
– Stop treating negatives to full on PBT
• 50 – 65% no treat with SDCT
– Use farm records to determine who to treat and not treat
• 20% of dairy operation antimicrobial use for mastitis
• 40% of dairy operation antimicrobial use for dry 
treatment
– Potential to reduce antimicrobial usage by 30 – 50 %
• Not reduction but prudent use
What if…?
• What would happen if antimicrobials were 
banned for use in food-producing animals?
– Inhumane? - YES
– We don’t want to find out
• What can we do to promote prudent or 
efficacious use of antimicrobials in the dairy 
industry and the food-producing animal 
industries?
Discussion
• Antimicrobials are necessary for humane treatment 
of animals
• Two pronged science based approach to prudent
use of antimicrobials
– PBT
– SDCT
• Pathogen based treatment in NY
– No increase in SCC, New and Chronic Infection rates at 
farms using PBT
– No increase in chronic MAST at farms using PBT
• Internationally antimicrobial usage has decreased 
with no negative impact on animal health
Pop quiz - review
• What is the percentage of mastitis cultures that are 
culture negative?
– 30-40%
• What percentage of mastitis causing organisms are 
treatable or respond to intramammary treatment?
– 10 – 40%
• How many dairy producers in the room will have a 
MAST No Treat protocol after today?
Questions
• Without bacteria we wouldn’t be alive
– Humans require bacteria for carbon, 
nitrogen and to digest food
• Cycling of chemical elements –
converting nitrogen to ammonia or 
nitrates to be absorbed by plants, which 
we eat and absorb to create amino 
acids and nucleic acid
• Digestion – without bacteria we 
wouldn’t break down all food – obtain 
more nutrition from food because of 
bacteria
• Without antimicrobials we would 
have a shorter lifespan
• It’s not about whether or not we 
should use antimicrobials, but 
instead implementing prudent use 
management strategies for 
antimicrobial use on dairy operations.  
